RSSCategory: Clinical Pathology

Inspirata, a Premier Sponsor and Exhibitor at Molecular Medicine Tri-Conference, to Host Presentations on Unlocking Precision Medicine Through Digital Pathology

| February 17, 2017 | 0 Comments

Stop by booth #120 to learn about Inspirata’s cancer diagnostics workflow solution and attend presentations by founder Dr. Mark Lloyd and precision medicine evangelist Dr. Mark Boguski. Tampa, FL, February 17, 2017/PRWeb – Cancer diagnostics workflow solution provider Inspirata, Inc., is a premier sponsor and exhibitor at Molecular Medicine Tri-Conference February 20 – 22 in […]

Continue Reading

Proscia Partners with Samsung Medical Center to Research Predictive Medicine in Cancer Diagnosis and Treatment

| February 13, 2017 | 0 Comments

Baltimore, MD — Proscia Inc., a data solutions provider for digital pathology, and Samsung Medical Center, South Korea’s preeminent clinical and biomedical research institute, today announced a partnership focused on developing tools that enable predictive medicine in the fight against cancer. The goal of the collaboration is to leverage mathematical oncology and novel deep-learning approaches to provide […]

Continue Reading

Different Sides of the Pond

| February 9, 2017 | 0 Comments

Great story in The Pathologist entitled “An Ocean Apart” — How pathology differs on either side of the Atlantic – and how it doesn’t by Michael Schubert What exactly is a boot? Or a biscuit? Or a chip? If you pictured part of a car, a sweet treat, and a French fry, you may be […]

Continue Reading

Trump Says ACA May Not Be Replaced Until Next Year

| February 6, 2017 | 0 Comments

Politico (2/5, Palmieri) reports that in an interview with Fox News’ Bill O’Reilly which aired before the Super Bowl, President Trump “walked back his recent vow that Obamacare would be replaced in short order,” saying that “the process is ‘complicated’ and ‘maybe it’ll take till sometime into next year.’” Trump said, “It statutorily takes a […]

Continue Reading

Will Not Using Image Analysis in Pathology be Perceived as Irresponsible? 

| February 1, 2017 | 0 Comments

Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com.  It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More quantitative analysis. Better, faster, cheaper, more accurate. Image analysis and tele-consultation have been and will […]

Continue Reading

The Future of Anatomic Pathology – 2 Possible Outcomes and More

| January 31, 2017 | 2 Comments

allthingspath.com had a recent interesting post on 2 possible outcomes for anatomic pathology at some point in the future of anatomic pathology.  One scenario is related to whole slide imaging and the other one is related to in vivo microscopy.  We are asked – Which one of these prevails? In my opinion, both.  There will […]

Continue Reading

Breast Imaging Company MammoLink℠ Rings in the New Year with Bold Predictions

| January 31, 2017 | 1 Comment

This looks interesting.  Wonder if this will generate more mammograms, more abnormal mammograms and more breast biopsies with potential to detect disease at an earlier stage. Does sound like a bold prediction putting the technology at point of care in primary care and ob-gyn offices.  Startup breast imaging company, MammoLink℠, is improving breast cancer screening by […]

Continue Reading

Tweeting Pathologists: How #InSituPathologists Changed the Way Pathologists Communicate

| January 25, 2017 | 0 Comments

A paper was recently published in Modern Pathology (ePub ahead of print) entitled “#InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of Pathology that details the activity of “live tweeting” the USCAP 2015 and USCAP 2016 and how it all got […]

Continue Reading

PRESS RELEASE: Innovative Anatomic Pathology Groups Use New Strategies to Increase Revenue and Maximize Pathologists’ Income Despite Unprecedented Price Cuts, Exclusionary Narrow Networks and Tougher Payer Audits

| January 23, 2017 | 0 Comments

PRESS RELEASE   THE DARK REPORT 21806 Briarcliff Dr. Spicewood, Texas 78669 512-264-7103 o 512-264-0969 f   FOR IMMEDIATE RELEASE Media Contact: Chris Garcia chris@darkreport.com   AUSTIN, Texas (January 16, 2017) It is the worst financial environment for the anatomic pathology profession in decades. Across the nation, pathology groups are coping with falling revenue, rising […]

Continue Reading

New Book on Digital Pathology Published

| January 22, 2017 | 0 Comments

A new book entitled, appropriately, “Digital Pathology” has recently been published by ASCP Press, edited by the well-known tag team of Dr. Liron Pantanowitz of UPMC and Dr. Anil Parwani of The Ohio State University. Anil and Liron have nearly 40 years of combined experience in digital pathology across a wide range of areas. The […]

Continue Reading

Epigenetics Changes Promote Pancreatic Cancer Metastasis

| January 20, 2017 | 0 Comments

Courtesy of Clinical OMICs – Molecular Diagnostics in Personalized Medicine Johns Hopkins researchers have published new data that suggests epigenetic changes controlling how DNA operates, provides survival advantages to a subset of pancreatic cancer cells. The results, published in the Nature Genetics article, “Epigenomic Reprogramming during Pancreatic Cancer Progression Links Anabolic Glucose Metabolism to Distant Metastasis,” […]

Continue Reading

Liquid Biopsies About to Get a Billion Dollar Boost

| January 18, 2017 | 0 Comments

Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the cancer-detection startup Grail Bio’s are, it might not be enough. As CEO and […]

Continue Reading

Register Now for CAP Webinar on HER2 Testing in Gastroesophageal Adenocarcinoma

| January 13, 2017 | 0 Comments

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive advanced GEA. Because there are important differences in HER2 expression, scoring, and outcomes in GEA relative to breast carcinoma, the need for guideline recommendations […]

Continue Reading

To Sign Out or Not to Sign Out? Part 2: The Fax Machine

| January 13, 2017 | 0 Comments

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from clinicians and patients about getting their results in a timely manner. […]

Continue Reading